Études cliniques de phases 0, 1 et 2 en cancérologie : questions d'actualité, Bull Cancer, vol.97, issue.1, pp.55-63, 2010. ,
Clinical trials in oncology Medicine (Baltimore), pp.56-64, 2016. ,
Do molecularly targeted agents in oncology have reduced attrition rates? Nat Rev Drug Discov, pp.15-21, 2009. ,
Available from: http://www.ecancer .fr/content/download, 2015. ,
Trial watch: Phase II failures, Nat Rev Drug Discov, vol.10, issue.5, pp.2008-2010328, 2011. ,
DOI : 10.1038/nrd3439
Volunteers or victims: patients' views of randomised cancer clinical trials, British Journal of Cancer, vol.71, issue.6, 1995. ,
DOI : 10.1038/bjc.1995.245
Public Attitudes Toward Participation in Cancer Clinical Trials, Journal of Clinical Oncology, vol.21, issue.5, pp.830-835, 2003. ,
DOI : 10.1200/JCO.2003.02.105
Patient motivations surrounding participation in phase I and phase II clinical trials of cancer chemotherapy, British Journal of Cancer, vol.24, issue.6, pp.1001-1006, 2005. ,
DOI : 10.1136/bmj.327.7417.693
Clinical trial design in oncology, The Lancet Oncology, vol.5, issue.12, pp.759-63, 2004. ,
DOI : 10.1016/S1470-2045(04)01654-7
Modernizing Eligibility Criteria for Molecularly Driven Trials, Journal of Clinical Oncology, vol.33, issue.25, pp.2815-2835, 2015. ,
DOI : 10.1200/JCO.2015.62.1854
Early mortality and overall survival in oncology phase I trial participants: can we improve patient selection?, BMC Cancer, vol.165, issue.1, p.426, 2011. ,
DOI : 10.1093/aje/kwk052
90-Days mortality rate in patients treated within the context of a phase-I trial: How should we identify patients who should not go on trial?, European Journal of Cancer, vol.44, issue.11, pp.1536-1576, 2008. ,
DOI : 10.1016/j.ejca.2008.04.017
Pitfalls and limitations of a single-centre, retrospectively derived prognostic score for Phase I oncology trial participants ??? Reply to Fussenich et al.: A new, simple and objective prognostic score for Phase I cancer patients, European Journal of Cancer, vol.48, issue.4, pp.594-600, 2012. ,
DOI : 10.1016/j.ejca.2011.11.004
Patient Selection for Oncology Phase I Trials: A Multi-Institutional Study of Prognostic Factors, Journal of Clinical Oncology, vol.30, issue.9, pp.996-1004, 2012. ,
DOI : 10.1200/JCO.2010.34.5074
A new, simple and objective prognostic score for phase I cancer patients, European Journal of Cancer, vol.47, issue.8, pp.1152-60, 2011. ,
DOI : 10.1016/j.ejca.2010.12.028
Developing an objective marker to optimize patient selection and predict survival benefit in early-phase cancer trials, Cancer, vol.106, issue.2, pp.262-70, 2014. ,
DOI : 10.1002/cncr.28381
An Inflammation Based Score Can Optimize the Selection of Patients with Advanced Cancer Considered for Early Phase Clinical Trials, PLoS ONE, vol.44, issue.1, 2014. ,
DOI : 10.1371/journal.pone.0083279.t004
Development and validation of a model that predicts early death among cancer patients participating in phase I clinical trials investigating cytotoxics, Investigational New Drugs, vol.9, issue.1, 2009. ,
DOI : 10.1007/s10637-009-9224-x
Prediction of early death among patients enrolled in phase I trials: development and validation of a new model based on platelet count and albumin, British Journal of Cancer, vol.15, issue.7, pp.1025-1055, 2012. ,
DOI : 10.1002/cncr.24018
Clinical outcome and prognostic factors for patients treated within the context of a phase I study: the Royal Marsden Hospital experience, British Journal of Cancer, vol.15, issue.6, pp.1029-1062, 2008. ,
DOI : 10.1093/jnci/92.3.205
Prospective Validation of a Prognostic Score to Improve Patient Selection for Oncology Phase I Trials, Journal of Clinical Oncology, vol.27, issue.16 ,
DOI : 10.1200/JCO.2008.19.5081
Validation of the royal marsden hospital prognostic score in patients treated in the phase I clinical trials program at the MD Anderson Cancer Center, Cancer, vol.10, issue.5, pp.1422-1430, 2012. ,
DOI : 10.1002/cncr.26413
Patient Selection for Phase II Trials, American Journal of Clinical Oncology, vol.32, issue.2, pp.216-225, 2009. ,
DOI : 10.1097/COC.0b013e318172dccd
???Sufficient Life Expectancy???: An Amazing Inclusion Criterion in Cancer Phase II-III Trials, Journal of Clinical Oncology, vol.27, issue.26, pp.105-105, 2009. ,
DOI : 10.1200/JCO.2009.24.1810
Research electronic data capture (REDCap)???A metadata-driven methodology and workflow process for providing translational research informatics support, Journal of Biomedical Informatics, vol.42, issue.2, 2009. ,
DOI : 10.1016/j.jbi.2008.08.010
Impact of Precision Medicine in Diverse Cancers: A Meta-Analysis of Phase II Clinical Trials, Journal of Clinical Oncology, vol.33, issue.32, pp.3817-3842, 2015. ,
DOI : 10.1200/JCO.2015.61.5997
Comprendre la r??gression logistique, Journal Fran??ais d'Ophtalmologie, vol.36, issue.8, 2013. ,
DOI : 10.1016/j.jfo.2013.05.008
Qu'est-ce qu'une régression logistique ? Rev Mal Respir, Feb, vol.22, issue.1, pp.159-62, 2005. ,
Evidence-Based Medicine in Primary Care: An Overview, The Journal of the American Board of Family Medicine, vol.11, issue.1, pp.46-56, 1998. ,
DOI : 10.3122/15572625-11-1-46
Evidence-based medicine: What it is and what it is not, Injury, vol.37, issue.4, pp.302-308, 2006. ,
DOI : 10.1016/j.injury.2006.01.034
Evaluation of patients with advanced cancer using the karnofsky performance status, Cancer, vol.18, issue.8, pp.2220-2224, 1980. ,
DOI : 10.1002/1097-0142(19800415)45:8<2220::AID-CNCR2820450835>3.0.CO;2-Q
The Karnofsky performance status scale: An examination of its reliability and validity in a research setting, Cancer, vol.18, issue.9, pp.2002-2009, 1984. ,
DOI : 10.1002/1097-0142(19840501)53:9<2002::AID-CNCR2820530933>3.0.CO;2-W
Performance status of patients is the major prognostic factor at all stages of pancreatic cancer, International Journal of Clinical Oncology, vol.23, issue.5, 2013. ,
DOI : 10.1007/s10147-012-0474-9
Performance status is the single most important prognostic factor in lymphoma patients aged greater than 75 overriding other prognostic factors such as histology, Leukemia & Lymphoma, vol.4, issue.1, pp.149-51, 2008. ,
DOI : 10.1093/annonc/mdl034
Performance status rather than age is the key prognostic factor in second-line treatment of elderly patients with epithelial ovarian carcinoma. Cancer, pp.1961-1968, 2002. ,
Performance Status is a Predictor of Overall Survival of Elderly Patients With Muscle Invasive Bladder Cancer, The Journal of Urology, vol.177, issue.4, pp.1287-93, 2007. ,
DOI : 10.1016/j.juro.2006.11.060
Analysis of ECOG performance status in head and neck squamous cell carcinoma patients: association with sociodemographical and clinical factors, and overall survival, Supportive Care in Cancer, vol.38, issue.3, pp.2679-85, 2012. ,
DOI : 10.1007/s00520-012-1386-y
Performance status is the most powerful risk factor for early death among patients with advanced soft tissue sarcomaThe European Organisation for Research and Treatment of Cancer ??? Soft Tissue and Bone Sarcoma Group (STBSG) and French Sarcoma Group (FSG) study, British Journal of Cancer, vol.17, issue.10, pp.1544-50, 2011. ,
DOI : 10.1634/theoncologist.10-10-833
Anemia as an independent prognostic factor for survival in patients with cancer, Cancer, vol.308, issue.12, pp.2214-2235, 2001. ,
DOI : 10.1002/1097-0142(20010615)91:12<2214::AID-CNCR1251>3.0.CO;2-P
P-761 Is anemia a prognostic factor in small cell lung carcinoma (SCLC)? Lung Cancer, p.319, 2005. ,
P2-193: Anaemia as prognostic and predictive factor of non-small cell lung cancer patients treated with chemo and radiotheraphy ??? retrospective analysis, Journal of Thoracic Oncology, vol.2, issue.8, pp.646-647, 2007. ,
DOI : 10.1097/01.JTO.0000283851.86181.35
Anemia como factor pronóstico independiente en pacientes con carcinoma renal. Med Clínica, pp.407-420, 2009. ,
Anemia is the strongest prognostic factor for outcomes of 5-fluorouracil-based first-line chemotherapy in patients with advanced gastric cancer, Cancer Chemotherapy and Pharmacology, vol.40, issue.Suppl 2, pp.91-97, 2006. ,
DOI : 10.1007/s00280-005-0027-2
Anemia as a prognostic factor in cancer of the cervix: a preliminary report, Can Med Assoc J, vol.100, issue.23, pp.1100-1102, 1969. ,
Immunomonitoring and prognostic relevance of neutrophils in clinical trials, Seminars in Cancer Biology, vol.23, issue.3, pp.200-207 ,
DOI : 10.1016/j.semcancer.2013.02.001
Initial Hyperleukocytosis and Neutrophilia in Nasopharyngeal Carcinoma: Incidence and Prognostic Impact, PLOS ONE, vol.189, issue.9, p.136752, 2015. ,
DOI : 10.1371/journal.pone.0136752.s001
Preoperative Leukocytosis Imposes an Increased Risk of Recurrence and Death Among Patients With Nonendometrioid Endometrial Carcinoma, International Journal of Gynecological Cancer, vol.23, issue.2, 2013. ,
DOI : 10.1097/IGC.0b013e31827da21b
The prognostic significance of preoperative leukocytosis in epithelial ovarian carcinoma: A retrospective cohort study, Gynecologic Oncology, vol.132, issue.3 ,
DOI : 10.1016/j.ygyno.2014.01.010
Prognostic value of hypercalcaemia and leucocytosis in resected oral squamous cell carcinoma, British Journal of Oral and Maxillofacial Surgery, vol.52, issue.5, 2014. ,
DOI : 10.1016/j.bjoms.2014.02.014
The Prognostic Significance of Pretreatment Leukocytosis in Patients With Anal Cancer Treated With Radical Chemoradiotherapy or Radiotherapy, Diseases of the Colon & Rectum, vol.56, issue.9, pp.1036-1078, 2013. ,
DOI : 10.1097/DCR.0b013e31829ab0d4
Elevated White Blood Cell Count at the Time of Recurrence Diagnosis Is an Indicator of Short Survival in Patients With Recurrent Cervical Cancer, International Journal of Gynecological Cancer, 2012. ,
DOI : 10.1097/IGC.0b013e31826ea0eb
Tumor-related leukocytosis is linked with poor prognosis in patients with lung carcinoma. Cancer, 2001. ,
Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: An analysis of Japan Multinational Trial Organisation LC00-03, European Journal of Cancer, vol.45, issue.11, pp.1950-1958, 2009. ,
DOI : 10.1016/j.ejca.2009.01.023
Rate limiting factors in recruitment of patients to clinical trials in cancer research: descriptive study, BMJ, vol.327, issue.7410, pp.320-321, 2003. ,
DOI : 10.1136/bmj.327.7410.320
A randomised, multicentre clinical trial of specialised palliative care plus standard treatment versus standard treatment alone for cancer patients with palliative care needs: the Danish palliative care trial (DanPaCT) protocol, BMC Palliative Care, vol.157, issue.1, p.37, 2013. ,
DOI : 10.7326/0003-4819-157-6-201209180-00537
The systematic early integration of palliative care into multidisciplinary oncology care in the hospital setting (IPAC), a randomized controlled trial: the study protocol, BMC Health Services Research, vol.38, issue.February 2012, p.554, 2015. ,
DOI : 10.1186/s12913-015-1207-3
Comparison of two quality of life instruments for cancer patients: the Ferrans and Powers Quality of Life Index and the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire C30, J Soc Integr Oncol, vol.6, issue.1, p.13, 2008. ,
Patient Self-Reports of Symptoms and Clinician Ratings as Predictors of Overall Cancer Survival, JNCI Journal of the National Cancer Institute, vol.103, issue.24 ,
DOI : 10.1093/jnci/djr485